Anakinra Associated With Reduced Mortality Risk in Patients Hospitalized With Moderate to Severe COVID-19
In a systematic review, study authors assessed the effect of anakinra on mortality in patients hospitalized with COVID-19.
Lung Infections
High Demand for At-Home COVID-19 Tests Could Hamper Supply, Abbott Says
Demand for Abbott Laboratories’ at-home COVID-19 tests has reached “unprecedented” levels and supply may be limited in the coming weeks.
US to Be Removed From European Union Safe Travel List
Due to surging COVID-19 cases, the United States will be removed from the European Union’s “safe list” of countries.
Good Recovery at 1 Year for Most COVID-19 Hospital Survivors
Most hospital survivors of COVID-19 have good physical and functional recovery at one year after acute infection, but health status is lower than for controls.
Awake Prone Positioning May Prevent Intubation in COVID-19
For hospitalized patients with acute hypoxic respiratory failure due to COVID-19 who require respiratory support with a high-flow nasal cannula, awake prone positioning may reduce the need for intubation.
Record High COVID-19 Cases and Deaths Reported in Florida
COVID-19 cases and deaths in Florida are at record highs as the delta variant ravages the state and Republican Gov. Ron DeSantis holds firm on forbidding vaccine and mask mandates.
J&J Says Booster Shot Increases Immune Response to COVID-19
Johnson & Johnson reported Wednesday that a booster shot of its vaccine dramatically raised the levels of antibodies against COVID-19.
No Benefit Found for COVID-19 Convalescent Plasma in High-Risk Outpatients
Infusion of COVID-19 convalescent plasma with a high titer of antibodies does not prevent COVID-19 progression in outpatients at high risk for severe disease.
Long-Acting Monoclonal Antibodies Look Promising for COVID-19 Prevention
The randomized, double-blind, placebo-controlled, multicenter PROVENT trial included 5197 participants aged 18 years and older who would benefit from AZD7442.
mRNA Vaccine Effective Against Hospitalization Over 24-Week Period
The effectiveness of mRNA vaccination against COVID-19-associated hospitalization is sustained over a 24-week period.
- Loading...
Loading...
Next post in Lung Infection
Loading... 
Loading...